Prompt treatment of disseminated HSV‐2 infection in a patient with compromised cellular immunity: A case of aborted hemophagocytic lymphohistiocytosis?. Issue 9 (25th May 2020)

• Record Type: Journal Article
• Authors: Tsimpidakis, Antonios; Tsilingiris, Dimitrios; Remountaki, Eleni; Zouridaki, Eftychia; Rigopoulos, Dimitrios; Nicolaidou, Electra
• Is Part Of: Clinical case reports. Volume 8:Issue 9(2020)
• Page Start: 1628
• Page End: 1630
• Publication Date: 2020-05-25
• Subjects: disseminated HSV‐2 -- fingolimod -- hemophagocytic lymphohistiocytosis -- herpes simplex virus type 2; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.2961
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Recognition of unusual manifestations such as disseminated HSV or HSV‐related hemophagocytic lymphohistiocytosis among individuals with impaired cellular immunity and prompt treatment initiation are essential for a favorable outcome. Abstract : Recognition of unusual manifestations such as disseminated HSV or HSV‐related hemophagocytic lymphohistiocytosis among individuals with impaired cellular immunity and prompt treatment initiation are essential for a favorable outcome.